Apria Inc (APR) Quote

‘As previously described in several filings with the Securities and Exchange Commission, ResolutionRx entered into a Letter of Intent (“LOI”) with Cantheon Capital (“Cantheon”) on May 18, 2023 that describes an intended investment of US$3,125,000 in Series A Preference Shares to be issued by Resolut

Par for the course.

Eric Adams becomes first sitting NYC mayor to be indicted by grand jury in historic federal probe: sources

 https://nypost.com/2024/09/25/us-news/nyc-mayor-eric-adams-indicted-by-grand-jury-in-historic-federal-probe-sources/

Sub 600k market cap . Wow!

Amen to that

In the 8-k the an investment firm valued the Australian subsidiary at .90 cents for 25m evaluation. That one compound alone puts us right below 3c a share and that’s excluding the rest of the line up

I dont think they would need a massive R/s to uplist! The share structure isnt that bad. The float is awesome for a good run with the right update . This could go to dollars if they stop with the bad communication. And not delivering . We need meaty news and off she goes. I myself am playing

gtch itrade i agree with you on the fluff !! the fact of the matter is he disapeared for awhile and no posts at all ,,, i thought he might have been taken out of the loop since his firm was owed like close to a mil for his services ,,, good to see he is still standing brings renewed hope this cou

Too bad the idiots at LWLG did not raise funds when we were on that epic run. Still could have raised a substantial amount of funding with a PP after the NAS uplisting. The company would have been set for years. However they seem to like the vipers at LPC. I wonder why.

$ASII Lots of 👀's now #3 Most Read @ 1,509,886.

https://investorshub.advfn.com/boards/most_read.aspx

Great post, hnbadger1 ..
"Donanemab, like the two previously approved Alzheimer’s drugs, faces questions not only about its efficacy and the number of deaths among patients taking the drug but also about financial ties to drug makers among FDA advisory committee members. The BMJ has found tha

I know a guy locally that has that allergy. Definitely from a tick. I have pulled ticks off me every year. If you can see them....then shouldn't be a problem.. ever. The little tiny, babies are the bad ones. I usually pull them out of my groan.... arm pits...and anywhere else that is warm and w

Bro,
You are the one who has no clue what you are doing. Still hold your 10k by now? Have you loaded more?

This is the most vetted stock on this planet. At this stage, we don't need LP to tell us explicitly the path forward. She can certainly tell us after the approval. The pa

$AAPJ

$AAPJ DD
➡️Jan. 24, 2023 Cancel debt $2M Redtail LLC.
➡️$1.3M debt related to real estate offset with asset 1.3M on the book
➡️No plan to do RS in the future
➡️potential acquisition targets gun parts MFG to AI, BTC and blockchain stated July 27,2023

$AAPJ

$AAPJ DD
➡️Jan. 24, 2023 Cancel debt $2M Redtail LLC.
➡️$1.3M debt related to real estate offset with asset 1.3M on the book
➡️No plan to do RS in the future
➡️potential acquisition targets gun parts MFG to AI, BTC and blockchain stated July 27,2023

$AAPJ

$AAPJ DD
➡️Jan. 24, 2023 Cancel debt $2M Redtail LLC.
➡️$1.3M debt related to real estate offset with asset 1.3M on the book
➡️No plan to do RS in the future
➡️potential acquisition targets gun parts MFG to AI, BTC and blockchain stated July 27,2023

Jerry looks like the worst part of the storm is going west of you take care

$PRDL

Took more $PRDL T2 obvious bottom here fins coming by eom lots of patents only a matter of time before the news claps 👏. pic.twitter.com/JC5kVGjfgM

$PRDL

Took more $PRDL T2 obvious bottom here fins coming by eom lots of patents only a matter of time before the news claps 👏. pic.twitter.com/JC5kVGjfgM

$PRDL

Took more $PRDL T2 obvious bottom here fins coming by eom lots of patents only a matter of time before the news claps 👏. pic.twitter.com/JC5kVGjfgM

Results from the Phase 2b/3 clinical trial results of blarcamesine in Alzheimer’s patients will be published in a peer-reviewed journal.

This statement has been around since 2023, nearly two years, and there is still no sign of that elusive article (same goes for countless catalyst).

$GSAC sharing my DD based on recent financials: 1/3

✔️ NO dilution recently
✔️ NICE SS - public float 1.2B; more then 50% of OS is held by insiders; market cap 1.2M
✔️ PRODUCTS and SERVICES - technology for the industrial security and renewable energy markets

$GSAC sharing my DD based on recent financials: 1/3

✔️ NO dilution recently
✔️ NICE SS - public float 1.2B; more then 50% of OS is held by insiders; market cap 1.2M
✔️ PRODUCTS and SERVICES - technology for the industrial security and renewable energy markets

$GSAC sharing my DD based on recent financials: 1/3

✔️ NO dilution recently
✔️ NICE SS - public float 1.2B; more then 50% of OS is held by insiders; market cap 1.2M
✔️ PRODUCTS and SERVICES - technology for the industrial security and renewable energy markets